TY - JOUR
T1 - Patient evaluation and selection for transcatheter aortic valve replacement
T2 - The heart team approach
AU - Sintek, Marc
AU - Zajarias, Alan
PY - 2014/5
Y1 - 2014/5
N2 - Transcatheter aortic valve replacement (TAVR) has been shown to significantly impact mortality and quality of life in patients with severe aortic stenosis (AS) who are deemed high risk for surgical aortic valve replacement (SAVR). Essential to these outcomes is proper patient selection. The multidisciplinary TAVR heart team was created to provide comprehensive patient evaluation and aid in proper selection. This review with outline the history and components of the heart team, and delineate the team's role in risk and frailty assessment, evaluation of common co-morbidities that impact outcomes, and the complex multi-modality imaging necessary for procedural planning and patient selection. The heart team is critical in determining patient eligibility and benefit and the optimal operative approach for TAVR. The future of structural heart disease will certainly require a team approach, and the TAVR heart team will serve as the successful model.
AB - Transcatheter aortic valve replacement (TAVR) has been shown to significantly impact mortality and quality of life in patients with severe aortic stenosis (AS) who are deemed high risk for surgical aortic valve replacement (SAVR). Essential to these outcomes is proper patient selection. The multidisciplinary TAVR heart team was created to provide comprehensive patient evaluation and aid in proper selection. This review with outline the history and components of the heart team, and delineate the team's role in risk and frailty assessment, evaluation of common co-morbidities that impact outcomes, and the complex multi-modality imaging necessary for procedural planning and patient selection. The heart team is critical in determining patient eligibility and benefit and the optimal operative approach for TAVR. The future of structural heart disease will certainly require a team approach, and the TAVR heart team will serve as the successful model.
KW - Heart team
KW - Patient eligibility
KW - Patient selection
KW - Transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=84900029278&partnerID=8YFLogxK
U2 - 10.1016/j.pcad.2014.02.003
DO - 10.1016/j.pcad.2014.02.003
M3 - Article
C2 - 24838133
AN - SCOPUS:84900029278
SN - 0033-0620
VL - 56
SP - 572
EP - 582
JO - Progress in cardiovascular diseases
JF - Progress in cardiovascular diseases
IS - 6
ER -